Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

Market Cap	15.94B
Revenue (ttm)	2.85B
Net Income (ttm)	170.02M
Shares Out	1.12B
EPS (ttm)	0.15
PE Ratio	94.87
Forward PE	62.04
Dividend	0.09 (0.64%)
Ex-Dividend Date	Jun 14, 2024

Volume	13,360,743
Average Volume	9,237,901
Open	14.09
Previous Close	14.04
Day's Range	14.00 - 14.31
52-Week Range	12.93 - 23.45
Beta	1.13
RSI	49.45
Earnings Date	Apr 21, 2025

About SHE:300601

Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. Its marketed vaccines include SARS-COV-2 vaccines, HIB conjugate vaccines, 13-valent pneumococcal conjugate vaccines, recombinant hepatitis B vaccines, 23-valent pneumococcal polysaccharide vaccines, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccines, cell-free whitebait b-type haemophilus influenzae combined vaccines, and measles and rubella combined vaccines. The company’...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 1,913
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300601

Financial Performance

In 2024, SHE:300601's revenue was 2.65 billion, a decrease of -23.75% compared to the previous year's 3.48 billion. Earnings were 201.65 million, a decrease of -76.59%.